To obtain a free ticket, simply visit the members hub here and get your discount code then purchase a ticket as normal then just add the code to the Promotional Code box.
This event series is split over 3 separate dates in May; 12th, 19th and 26th May.
May series of virtual webinars have been organised by Academy of Pharmaceutical Sciences Advanced Therapy Medicinal Products (ATMPs) Focus Group. These will run in May for 3 consecutive weeks.
The APS are pleased to announce a unique opportunity of a virtual webinars which will introduce the scientific principles underlying Advanced Therapy Medicinal Products (ATMPs), focussed on cell and gene medicines. Presentations will encompass concepts of cell/organ targeted gene delivery, product processing, manufacture and working with regulatory agencies. The current understanding in each field will be discussed alongside known barriers and potential solutions to their development for clinical use.
This is a unique opportunity to join with experts from Academia, NHS and the Pharmaceutical Industry to explore drug delivery strategies, product development, manufacture, regulatory frameworks and the clinical trial process for cell and gene-based medicines.
Three webinars will run, 12, 19 and 26th May 2021
They will start at 1.00pm and we aim to finish at 3.00pm. There will be an opportunity for Q&A after the talks.
You can register for one seminar or for all three.
You will be sent a ZOOM INVITE a day before the event and then one hour before the start. Please click to join.
The meeting is suitable for those from across academic, industrial and health-care sectors who work or have an interest in cell and gene therapy and ATMP regulations. The broad scope will suit postgraduate students, early career scientists and those transitioning into the pharmaceutical sciences with a focus to ATMPs, or established regulatory experts wishing to gain further insight into the underpinning science and technology, and vice versa. Experts in the respective areas will present and there will be opportunity for discussion and debate within the forum.
ARPAN DESAI-Associate Principal Scientist, Advanced Drug Delivery, Pharmaceutical Science, Research and Development, Astra Zeneca, UK
Design and Delivery methods for gene therapies
CHRISTINE DUFES-Reader (Associate Professor) in Nanomedicine Strathclyde Institute of Pharmacy and Biomedical Sciences (SIPBS) Glasgow, UK
Development of gene-based nanomedicines for cancer therapy
CHRIS VAN DER WALLE-Director, Formulation, Cell & Gene Therapies, GlaxoSmithKline, UK
Formulation considerations for T-cell therapies
FRANK THIELMANN-Operational Excellence Director, Takeda Pharmaceutical Company, Switzerland
ZAHRA RATTRAY-Chancellor’s Research Fellow and Lecturer in Translational Pharmaceutics, Strathclyde Institute of Pharmacy and Biomedical Sciences (SIPBS). Glasgow UK
Short presentation on Manufacturing for advanced medicinal and therapeutic products followed by discussion and poster session.
JOANNE BROADHEAD-Vice President CMC Project Delivery
Freeline Therapeutics Limited, Stevenage Bioscience Catalyst, Gunnels Wood Road, Stevenage, Herts, SG1 2FX, UK
In vivo gene therapy: CMC challenges in clinical trials’
ALICE MASON-Lead Pharmacist, Advanced Therapy Medicinal Products
The Royal Marsden NHS Foundation Trust, London, UK
Clinical Applications and Trial Process
APS MEMBERS FREE FOR ALL THREE WEBINARS
Non-Members
Students and Early career researchers – £10 per webinar & £25 to attend all 3 webinars
Others- £20 per webinar and £50 to attend all 3 webinars
All prices ex VAT
1600 Amphitheatre Parkway New York WC1 1BA
Phone: 1.800.458.556 / 1.800.532.2112
Fax: 458 761-9562
Email: info@your-domain.com
Web: ThemeFusion
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.
